These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37798232)

  • 1. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.
    Sarzani R; Allevi M; Giulietti F; Sarnari S; Scorcella S; Di Agostini A; Turri P; Di Pentima C; Spannella F
    Nutr Metab Cardiovasc Dis; 2024 Jan; 34(1):136-144. PubMed ID: 37798232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions.
    Penson PE; Mancini GBJ; Toth PP; Martin SS; Watts GF; Sahebkar A; Mikhailidis DP; Banach M;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1023-1033. PubMed ID: 30311434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and statins: from toxicity to the nocebo effect.
    Pedro-Botet J; Climent E; Benaiges D
    Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
    Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
    Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
    J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
    Taylor BA; Thompson PD
    Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.
    Chen W; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Future Cardiol; 2022 Jun; 18(6):461-470. PubMed ID: 35297269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features related to statin-associated muscle symptoms.
    Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
    Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
    J Clin Lipidol; 2024; 18(2):e269-e284. PubMed ID: 38177036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
    Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin withdrawal on perceived and objective muscle function.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
    PLoS One; 2023; 18(6):e0281178. PubMed ID: 37315062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
    Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
    Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
    Iatan I; Mancini GBJ; Yeoh E; Hegele RA
    Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on SAMS: Statin-associated muscle symptoms.
    Stock JK
    Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
    Brennan ET; Joy TR
    Can J Cardiol; 2017 May; 33(5):666-673. PubMed ID: 28449837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
    Cho L; Rocco M; Colquhoun D; Sullivan D; Rosenson RS; Dent R; Xue A; Scott R; Wasserman SM; Stroes E
    Cardiovasc Drugs Ther; 2016 Jun; 30(3):297-304. PubMed ID: 26936841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.